Evidence map›Paper›PMID 27083045›Full record

ArticleeLife2016

Acute inhibition of neurosteroid estrogen synthesis suppresses status epilepticus in an animal model.

Satoru M Sato, Catherine S Woolley

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. A neural circuit perspective on brain aromatase.Frontiers in neuroendocrinology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Satoru M SatoDepartment of Neurobiology, Northwestern University, Evanston, United States.
Catherine S WoolleyDepartment of Neurobiology, Northwestern University, Evanston, United States.ORCID 0000-0002-8069-2646
Northwestern University · US

Funding

Estrogen-Induced Hippocampal Seizure SusceptibilityR01NS037324 · NINDS · NORTHWESTERN UNIVERSITY · PI WOOLLEY, CATHERINE S · 2003 to 2013
$3.1M
NINDS NIH HHS R01 NS037324
6 · The paper itself

Abstract

Status epilepticus (SE) is a common neurological emergency for which new treatments are needed. In vitro studies suggest a novel approach to controlling seizures in SE: acute inhibition of estrogen synthesis in the brain. Here, we show in rats that systemic administration of an aromatase (estrogen synthase) inhibitor after seizure onset strongly suppresses both electrographic and behavioral seizures induced by kainic acid (KA). We found that KA-induced SE stimulates synthesis of estradiol (E2) in the hippocampus, a brain region commonly involved in seizures and where E2 is known to acutely promote neural activity. Hippocampal E2 levels were higher in rats experiencing more severe seizures. Consistent with a seizure-promoting effect of hippocampal estrogen synthesis, intra-hippocampal aromatase inhibition also suppressed seizures. These results reveal neurosteroid estrogen synthesis as a previously unknown factor in the escalation of seizures and suggest that acute administration of aromatase inhibitors may be an effective treatment for SE.

Indexed as

AnimalsAromatase InhibitorsDisease Models, AnimalEstradiolHippocampusInhibition, PsychologicalKainic AcidNeurotransmitter AgentsRatsStatus EpilepticusTreatment OutcomeAromatase InhibitorsEstradiolKainic AcidNeurotransmitter Agentsestradiolhippocampuskainic acidmicrodialysisneuroscienceratseizure

Identifiers

PMID27083045
PMCPMC4862752
OpenAlexW2339646613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.